Percutaneous Patent Foramen Ovale Closure in Patients with Cryptogenic Stroke or Transient Ischemic Attack: A Retrospective Study
Table 3
Results of follow-ups in eleven patients after PFO closure.
Patient ID
Follow-up (month)
Current antiplatelet therapy
mRS score
Residual RLS detected by cTTE after PFO closure
1
41
Aspirin
0
No RLS detected after 15 months
2
40
Aspirin
1
/
3
28
No
0
No RLS detected after 7 months
4
27
No
1
No RLS detected after 7 months
5
25
Aspirin
1
No RLS detected after 6 months
6
24
No
0
No RLS detected after 7 months
7
22
Aspirin
0
No RLS detected after 6 months
9
17
Aspirin
1
/
10
15
Aspirin
0
/
11
27
No
0
No RLS detected after 7 months
12
26
No
0
/
“/” represents: RLS reexamination by cTTE was not performed on these patients during follow-up. Patient ID 8 was absent because the PFO closure procedure could not be completed in this patient.
